Medpace Soars After Q2 Beat, Strong Backlog Fuels Higher 2026 Outlook
Medpace says second-quarter earnings and revenue beat estimates, backed by stronger bookings, backlog growth and higher 2026 guidance.
Medpace made more money than expected last quarter and has lots of new work lined up, so they're saying they'll do even better next year. When a company beats expectations and has a big backlog (work waiting to be done), it suggests the business is humming and customers trust them.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.